Analystreport

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.

Alnylam Pharmaceuticals, Inc.  (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview